These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12902419)

  • 1. Immuno-PET for tumor targeting.
    Lee FT; Scott AM
    J Nucl Med; 2003 Aug; 44(8):1282-3. PubMed ID: 12902419
    [No Abstract]   [Full Text] [Related]  

  • 2. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in nucleoside tracers for PET imaging of cell proliferation.
    Toyohara J; Fujibayashi Y
    Nucl Med Biol; 2003 Oct; 30(7):681-5. PubMed ID: 14499325
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular transport mechanisms of radiolabeled amino acids for PET and SPECT.
    Langen KJ; Bröer S
    J Nucl Med; 2004 Sep; 45(9):1435-6. PubMed ID: 15347708
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis.
    Jain M; Batra SK
    J Nucl Med; 2003 Dec; 44(12):1970-2. PubMed ID: 14660723
    [No Abstract]   [Full Text] [Related]  

  • 7. Applications of positron-emitting halogens in PET oncology (Review).
    Glaser M; Luthra SK; Brady F
    Int J Oncol; 2003 Feb; 22(2):253-67. PubMed ID: 12527920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of labeling monoclonal antibodies for positron emission tomography and magnetic resonance imaging.
    Welch MJ
    Acta Radiol Suppl; 1990; 374():129-33. PubMed ID: 1966959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.
    Meijs WE; Haisma HJ; Klok RP; van Gog FB; Kievit E; Pinedo HM; Herscheid JD
    J Nucl Med; 1997 Jan; 38(1):112-8. PubMed ID: 8998164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
    Brouwers A; Verel I; Van Eerd J; Visser G; Steffens M; Oosterwijk E; Corstens F; Oyen W; Van Dongen G; Boerman O
    Cancer Biother Radiopharm; 2004 Apr; 19(2):155-63. PubMed ID: 15186595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?
    Van Dongen GA; Huisman MC; Boellaard R; Harry Hendrikse N; Windhorst AD; Visser GW; Molthoff CF; Vugts DJ
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):18-38. PubMed ID: 25517081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor PET imaging with Gallium-68 labeled peptides.
    Win Z; Al-Nahhas A; Rubello D; Gross MD
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):244-50. PubMed ID: 17464267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The folate receptor as a molecular target for tumor-selective radionuclide delivery.
    Ke CY; Mathias CJ; Green MA
    Nucl Med Biol; 2003 Nov; 30(8):811-7. PubMed ID: 14698784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-PET: a navigator in monoclonal antibody development and applications.
    van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
    Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine.
    Signore A; Chianelli M; Bei R; Oyen W; Modesti A
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):149-56. PubMed ID: 12520385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
    Mariani G; Erba PA; Signore A
    J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioimmunodetection of a tumor with Ga-67 labeled antibodies: effect of radiolabeling on antibody activities].
    Furukawa T; Endo K; Ohmomo Y; Sakahara H; Koizumi M; Nakashima T; Fukunaga M; Morita R; Hirai H; Yokoyama A
    Kaku Igaku; 1986 Apr; 23(4):337-43. PubMed ID: 3735781
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On measuring hypoxia in individual tumors with radiolabeled agents.
    Chapman JD; Zanzonico P; Ling CC
    J Nucl Med; 2001 Nov; 42(11):1653-5. PubMed ID: 11696634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.